Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06682793 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 10 sites in the US |
| Sponsor | A2 Biotherapeutics Inc. |
| Last Updated on CT.gov | September 9, 2025 (Sep 9, 2025) |
As of March 2, 2026: Clinical trial NCT06682793 is currently recruiting participants. This clinical trial study for solid tumors is actively seeking new participants at 10 locations across the United States. The study is sponsored by A2 Biotherapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06682793 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06682793 was last updated Sep 9, 2025 (September 9, 2025). HelloStudys verifies this status automatically.